OC-0102 DBCG phase III randomized trial of hypo- vs standard fractionated RT in 2879 pN+ breast cancer pts.
Saved in:
| Title: | OC-0102 DBCG phase III randomized trial of hypo- vs standard fractionated RT in 2879 pN+ breast cancer pts. |
|---|---|
| Authors: | Offersen, B. (AUTHOR), Alsner, J. (AUTHOR), Nielsen, H.M. (AUTHOR), Bechmann, T. (AUTHOR), Nielsen, M.H. (AUTHOR), Mjaaland, I. (AUTHOR), Kamby, C. (AUTHOR), Krkove, C. (AUTHOR), Lorincz, T. (AUTHOR), Al-Rawi, S. (AUTHOR), Stoere, E.B. (AUTHOR), Schreiber, A. (AUTHOR), Krause, M. (AUTHOR), Kasti, U. (AUTHOR), Matthiessen, L.W. (AUTHOR), Kedzierawski, P. (AUTHOR), Marinko, T. (AUTHOR), Luukkaa, M. (AUTHOR), Skyttä, T. (AUTHOR), Jensen, M. (AUTHOR) |
| Source: | Radiotherapy & Oncology. 2022 Supplement 1, Vol. 170, pS76-S77. 2p. |
| Subjects: | Clinical trials, Breast cancer |
| Database: | Engineering Source |
| ISSN: | 01678140 |
|---|---|
| DOI: | 10.1016/S0167-8140(22)02478-1 |
